Find a Doctor

Andrew C. Wood, MBChB

Attending Physician


2011, Translational Science Award, SIOP Annual Congress

2010, AACR Molecular Biology in Clinical Oncology Works

2009, Travel award to international workshop

2008, AMP Scholarship

2007, Child Cancer Foundation Professional Development Grant

2007, Genesis Oncology Trust, Professional Development Award

2007, Fulbright Scholarship – Ministry of Research, Science, and Technology Award

2006, Edward Roche Memorial Travel Grant

Original Papers


Bresler SC, Wood AC, Haglund EA, Courtright J, Belcastro LT, Plegaria JS, et al. Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma. Sci Transl Med 2011 Nov 9. Cited in PubMed; PMID: 22072639. Read the article

Cole KA, Huggins J, Laquaglia M, Hulderman CE, Russell MR, Bosse K, et al. RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3336-41. Cited in PubMed; PMID: 21289283. Read the article


Balamuth NJ, Wood A, Wang Q, Jagannathan J, Mayes P, Zhang Z, et al. Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target. Cancer Res. 2010 Mar 16. Cited in PubMed; PMID: 20233875. Read the article


Mossé YP, Wood A, Maris JM. Inhibition of ALK signaling for cancer therapy. Clin Cancer Res. 2009 Sep 15;15 (18):5609-14. Cited in PubMed; PMID: 19737948. Read the article

Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, Bosse K, et al. Copy number variation at 1q21.1 associated with neuroblastoma. Nature. 2009 Jun 18;459 (7249):987-91. Cited in PubMed; PMCID: PMC2755253. Read the article

« Back to Previous Page
  • Print
  • Share

Contact Us